Latest / Toronto News Today | 2 Min News | The Daily News Now!
EU Approves First Lyme Vaccine | Toronto News
A breakthrough could be on the horizon: the EU is reviewing a new Lyme disease vaccine developed by Pfizer and Valneva, showing 70% effectiveness in trials. With Lyme now the most common tick-borne illness—and no vaccine available—this could be a game-changer, especially as climate change expands tick habitats. The news sent Valneva’s stock soaring 16%, highlighting global urgency as over 14% of people worldwide have had Lyme at some point. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.